LLC "LancetXXIcentury":4 times turnover growth vs previous Responsibility of full scope of business operations and P&L responsibility Marketing strategy development Team bulding & motivation scheme implementationFull cycle of licensing procedure in MOH for extention of the services list.In Berlin-Chemie/Menarini 1. Berlithion (thioctic acid) – sales increase + 50% (2011 vs 2007 yy);2. Creation and implementation of “Crisis Action Plan” for Iodomarin (potassium iodine), which leaded to sales growth recovery since 2010 and achieved MS appr. 98%;3. Launch of Zibor (LMWH) in 2008 with achievement of 2rd position (Euro) on Total anticoagulant market (with limited dose range registered); best sales in Berlin-Chemie International Division ( 2013).4. Creation and implementation of “Crisis Action Plan” for Mezym Forte (pancreatic enzyme preparation (PEP), which leaded to sales growth recovery since July 2011; return of position №1 on the PEP market; "Plan of development of Pangrol.5. Preparation and implementation of post marketing clinical study(PMCS) START-I, START-II for Berlithion; PMCS for assessment the efficasy and safety Zibor and Dexalgin in large orthopaedic practice; PMCS for assessment efficasy and safety of stepped pancreatic enzymes therapy.6. Creation and management of major multispecialty national educational projects “SCHOOLS"​: Thyreo, Thromboprophylaxis and Gastro with support of majority of National and Regional opinion leaders with average 400 attendees in each region (max 1100), total 35 schools in 2010-15 yy.7. Keeping leading position of L-Thyroxin BC (levothyroxin, ATC class H03A) and doubling sales over the last 5 years.In STADA CIS company:1. Most of the managed brands became “drugs - millionairs"​ and market leaders:- Hondroxid, Hexicon, Livarol2. Aminosol and Gepasol - 2nd place on the market segment of infusions for parenteral nutrition, launch of new lines;3. Creation and implementation local training programs for MRs